Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity. This evidence concerns the gene HDAC9 and intrahepatic cholangiocarcinoma.